ChemicalBook--->CAS DataBase List--->53648-55-8

53648-55-8

53648-55-8 Structure

53648-55-8 Structure
IdentificationBack Directory
[Name]

Dezocine
[CAS]

53648-55-8
[Molecular Formula]

C16H23NO
[MOL File]

53648-55-8.mol
[Molecular Weight]

245.36
Chemical PropertiesBack Directory
[Boiling point ]

392.6±42.0 °C(Predicted)
[density ]

1.082±0.06 g/cm3(Predicted)
[pka]

10.06±0.40(Predicted)
Safety DataBack Directory
[RIDADR ]

3249
[HazardClass ]

6.1(b)
[PackingGroup ]

III
Raw materials And Preparation ProductsBack Directory
[Raw materials]

Activated carbon,decolor
Hazard InformationBack Directory
[Description]

Dezocine is an injectable agonisthtagonist analgesic indicated when an opioid analgesic is suitable for the management of pain. The drug differs from other opioid agonisthtagonists by having a high affinity for both the mu and delta receptors and a low effect on kappa receptors. Dezocine is reported to have a rapid onset of action, short half-life and low abuse potential with insignificant side effects.
[Originator]

Wyeth-Ayerst (American Home Products) (U.S.A.)
[Uses]

Dezocine is an opioid analgesic that is related to Pentazocine (P274300). Dezocine is used to relieve post-operative pain with its potency comparable to Meperidine (M223900).
[Definition]

ChEBI: (7S,8S)-7-Amino-8-methyl-5,6,7,8-tetrahydronaphthalen-2-ol in which the hydrogen at position 8 and one of the hydrogens at position 6 are substituted by each end of a tetramethylene bridge. A synthetic opioid analgesic, it has mixed opiod agonist and antagonist properties. Although it is used for pain management, it can produce opioid withdrawal syndrome in patients already dependent on other opioids, and its clinical application is limited by side effects such as dizziness.
[Brand name]

Dalgan (AstraZeneca).
[Biological Functions]

Dezocine (Dalgan) is a synthetic aminotetralin derivative with potent agonist–antagonist effects.The onset of activity and potency as an analgesic are comparable to those of morphine. Although the drug requires glucuronidation during metabolism, patients with hepatic insufficiency clear it normally.The main route for clearance is the kidney.Thus, patients with renal dysfunction are prone to buildup of dezocine over time. As an antagonist, dezocine is more potent than pentazocine. As an agonist, dezocine produces analgesia and respiratory depression (which is readily reversed by naloxone), but unlike pentazocine, it has little if any effect on the cardiovascular system.
Dezocine is indicated as an analgesic for moderate to severe pain. In addition, it shows promise in chronic pain states, such as with victims of severe burns. Contraindications and adverse effects of the drug are similar to those described for morphine. No tendency toward abuse has been demonstrated thus far.
Tags:53648-55-8 Related Product Information
96-05-9 143390-89-0 99-98-9 734-32-7 5380-42-7 79-20-9 80-71-7 26472-00-4 96-33-3 110-93-0 77-86-1 99-76-3 298-00-0 74-83-9